Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2009
Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cancer Group)P O Witteveen, J van der Velden, I Vergote, et al.
European Journal of Gynaecological Oncology|March 5, 2002
Treatment of metastatic invasive moles in two husband-side sisters-in-law. Case reports and review of literatureM A Van Eijkeren, E A Sijmons, P O Witteveen, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 25, 2007
[Skin eruptions as an adverse reaction to epidermal growth-factor receptor inhibitors]M L R Tjin-A-ton, C van Montfrans, J J Koldenhof, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 4, 2001
Is platinum-based chemotherapy with paclitaxel effective in optimally debulked patients with advanced ovarian cancer?J P Roovers, E A Sijmons, J H van Leeuwen, et al.
Gynecologic Oncology Reports|August 5, 2025
The added value of chemotherapy after secondary cytoreductive surgery in unifocal versus multifocal first recurrent epithelial ovarian cancer: A systematic reviewR E W M van de Vorst, M D Huiskamp, E H Gort, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1995
An EORTC pilot study of filgrastim (recombinant human granulocyte colony stimulating factor) as support to a high dose-intensive epiadriamycin-cyclophosphamide regimen in chemotherapy-naive patients with locally advanced or metastatic breast cancerM J Piccart, P Bruning, J Wildiers, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 2, 2014
Symptoms from treatment with sunitinib or sorafenib: a multicenter explorative cohort study to explore the influence of patient-reported outcomes on therapy decisionsJ J Koldenhof, P O Witteveen, R de Vos, et al.
Investigational New Drugs|January 25, 2013
Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumorsF E Stuurman, E E Voest, A Awada, et al.
Breast Cancer Research and Treatment|February 2, 2019
Tamoxifen and pregnancy: an absolute contraindication?T N Schuurman, P O Witteveen, E van der Wall, et al.
Gynecologic Oncology|July 14, 2018
Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancerM Timmermans, M A van der Aa, R I Lalisang, et al.
Pageof 4